Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high-risk KMT2A-rearranged acute myeloid leukaemia.
0/5 보강
APA
Chavan A, Frett B, et al. (2025). Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high-risk KMT2A-rearranged acute myeloid leukaemia.. British journal of haematology, 207(6), 2563-2568. https://doi.org/10.1111/bjh.70183
MLA
Chavan A, et al.. "Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high-risk KMT2A-rearranged acute myeloid leukaemia.." British journal of haematology, vol. 207, no. 6, 2025, pp. 2563-2568.
PMID
40976985 ↗